← Back to all trials
Not Yet Recruiting
NCT05705856
Effectiveness and Safety of Ustekinumab Intensification in Crohn's Disease
Conditions: Crohn Disease
Sex: All
Ages: 18 Years – N/A
Enrollment: 200
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
The primary purpose of this study is to evaluate the efficacy and safety of intravenous reinduction or intravenous administration at regular intervals of ustekinumab in participants with loss of response to standard regimen.
Eligibility Criteria
Inclusion Criteria:Agree to participate in the studyWith active Crohn's diseasePatients undergoing UST dose intensification were either received intravenous ustekinumab at regular intervals or, alternatively, received an intravenous reinduction (6 mg/kg) instead of a scheduled SC dose at the discretion of the treating physicianExclusion Criteria:who had received ustekinumab for an indicationpregnant or nursing
Source: ClinicalTrials.gov (NCT05705856). StuddyBuddy aggregates publicly available trial information.
